Pharmac's funding trastuzumab deruxtecan , branded as Enhertu, from today - along with a lung cancer drug and two respiratory treatments. Enhertu is expected to help 120 people with HER2-positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results